BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6623019)

  • 1. A comparison between clinical and laboratory tests in rheumatoid arthritis.
    Grindulis KA; Calverley M; Constable TJ; Forster PJ; Ahmed ME; McConkey B
    Scand J Rheumatol; 1983; 12(3):285-8. PubMed ID: 6623019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between erythrocyte sedimentation rate and serum C-reactive protein in rheumatoid arthritis.
    Walsh L; Davies P; McConkey B
    Ann Rheum Dis; 1979 Aug; 38(4):362-3. PubMed ID: 496450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of clinical assessments of disease activity in rheumatoid arthritis.
    Rhind VM; Bird HA; Wright V
    Ann Rheum Dis; 1980 Apr; 39(2):135-7. PubMed ID: 7387217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence-based approach to laboratory tests in usual care of patients with rheumatoid arthritis.
    Pincus T; Gibson KA; Shmerling RH
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-23-8. PubMed ID: 25365085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alpha 1 antichymotrypsin concentration as a marker of disease activity in rheumatoid arthritis.
    Chard MD; Calvin J; Price CP; Cawston TE; Hazleman BL
    Ann Rheum Dis; 1988 Aug; 47(8):665-71. PubMed ID: 3261967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
    Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
    Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein levels in patients with rheumatoid arthritis: the impact of therapy.
    Tishler M; Caspi D; Yaron M
    Clin Rheumatol; 1985 Sep; 4(3):321-4. PubMed ID: 4064588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
    Chandrashekara S; Priyanka BU
    Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
    Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
    Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of erythrocyte sedimentation rate (ESR) and C- reactive protein (CRP) on rheumatoid arthritis activity prediction].
    Silva I; Mateus M; Branco JC
    Acta Reumatol Port; 2010; 35(5):456-62. PubMed ID: 21245814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment.
    Amos RS; Crockson RA; Crockson AP; Walsh L; McConkey B
    Br Med J; 1978 May; 1(6124):1396. PubMed ID: 647307
    [No Abstract]   [Full Text] [Related]  

  • 13. A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study.
    Amalraj A; Varma K; Jacob J; Divya C; Kunnumakkara AB; Stohs SJ; Gopi S
    J Med Food; 2017 Oct; 20(10):1022-1030. PubMed ID: 28850308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.
    Syngle A; Vohra K; Garg N; Kaur L; Chand P
    Int J Rheum Dis; 2012 Feb; 15(1):45-55. PubMed ID: 22324946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid arthritis: effects of a new agent (ICI 55 897) on serum acute phase proteins and the erythrocyte sedimentation rate.
    McConkey B; Amos RS; Billingham ME; Constable TJ; Crockson RA; Crockson AP; Forster PJ
    Ann Rheum Dis; 1980 Feb; 39(1):18-21. PubMed ID: 6990881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
    Gerber LH; Furst G; Yarboro C; el-Gabalawy H
    Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma viscosity--a new appraisal of its use as an index of disease activity in rheumatoid arthritis.
    Pickup ME; Dixon JS; Hallett C; Bird HA; Wright V
    Ann Rheum Dis; 1981 Jun; 40(3):272-5. PubMed ID: 7247471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
    Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
    Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcemia and Lytic Bone Lesions Masquerading Inflammatory Arthritis Treated as Rheumatoid Arthritis.
    Salari M; Aboutorabi RB; Rezaieyazdi Z
    Arch Iran Med; 2015 Oct; 18(10):720-3. PubMed ID: 26443255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of rheumatoid arthritis following adjunct statin therapy.
    Das S; Mohanty M; Padhan P
    Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.